Financial Summary (All financials)
In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
Revenues | 11.2 | 11.1 | 10.7 | 9.5 | 9.2 | 8.3 |
Revenue growth | 0.1% | 4.1% | 13.0% | 3.2% | 10.1% | |
Cost of goods sold | 6.7 | 5.9 | 5.7 | 5.7 | 5.2 | 4.6 |
Gross profit | 4.5 | 5.2 | 5.0 | 3.8 | 4.0 | 3.7 |
Gross margin | 39.9% | 46.8% | 46.9% | 40.2% | 43.2% | 44.7% |
Sales and marketing | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.2 |
General and administrative | 2.7 | 2.1 | 2.2 | 2.2 | 1.9 | 1.7 |
EBIT | 1.4 | 2.3 | 2.5 | 1.3 | 1.7 | 1.8 |
EBIT margin | 12.9% | 20.4% | 23.3% | 13.6% | 18.2% | 21.1% |
Pre-tax income | 0.6 | 2.4 | 2.3 | 1.2 | 1.5 | 1.6 |
Income taxes | 0.4 | 0.9 | 0.9 | 0.4 | 0.6 | 0.6 |
Tax rate | 68.2% | 38.0% | 36.5% | 36.4% | 37.1% | 36.6% |
Net income | 0.2 | 1.5 | 1.5 | 0.7 | 0.9 | 1.0 |
Net margin | 1.7% | 13.6% | 13.8% | 7.8% | 10.3% | 12.1% |
|
Diluted EPS | $0.11 | $0.86 | $0.85 | $0.41 | $0.51 | $0.53 |
Shares outstanding (diluted) | 1.8 | 1.8 | 1.7 | 1.8 | 1.9 | 1.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|